Hodgkin's disease therapeutic program.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008466:Mechlorethamine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004338:Drug Combinations; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone